Martin E. Shmagin

Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California.

Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS.

Regenesis Biomedical, Inc. operates as a medical technology company which designs, manufactures, and markets energy-based medical products and services. The firm offers Provant therapy system for the palliative treatment of post-operative pain and edema in superficial soft tissue. The company was founded by Frank R. George and Mary C. Ritz in 1997 and is headquartered in Scottsdale, AZ.

TheraVida, Inc. develops and commercializes therapeutic products that improve the lives of patients. The firm's products help to treatment of overactive bladder and urge urinary incontinence. It develops a portfolio of combination pharmaceutical products in the fields of urology and central nervous system disorders. The company was founded by Mehdi Paborji in 2005 and is headquartered in Chapel Hill, NC.

TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA.

Aggredyne, Inc. develops laser light scattering platelet aggregometer that provides a full profile of a patient’s responsiveness to their anti-platelet medications. The company was founded by Edward R. Teitel and Robert C. Hux in 2011 and is headquartered in Houston, TX.

Russell Reynolds Associates, Inc. provides executive recruitment services. Its services include chief executive officer and board advisory services, culture assessment, executive search, global supply chain and leadership assessment. The company was founded in 1969 and is headquartered in New York, NY.

Part of Gilead Sciences, Inc., IBC Pharmaceuticals, Inc. is a company that produces biological products. The company is based in Morris Plains, NJ.

University of Houston System offers higher education degrees and job training or vocational study programs. It offers about 280 undergraduate and graduate degree programs in fields such as business, education, humanities and law. It was founded in 1927 and is headquartered in Houston, TX.

R.J. Watkins & Co. Ltd. provides executive recruiting and consulting services to select clients on a global basis. The firm recruits senior-level executives including CEOs and vice presidents for the companies in technology, life sciences, not-for-profit, and general business sectors. It has offices in Hong Kong, London, San Diego, San Francisco, and Silicon Valley. The company was founded by Robert J. Watkins in 1980 and is headquartered in San Diego, CA.

Aztec Venture Network LLC provides seed capital and mentoring resource services. The company is headquartered in San Diego, CA.

Long Shadows Asset Management LLC provides investment advice. The private company is based in Burlingame, CA.

Auration Biotech, Inc. develops novel therapeutics for the treatment of diseases of the ear, nose, and throat. The private company is based in Dover, DE. The company was founded by Sanjay Chanda. Benjamin F. McGraw has been the CEO of the company since 2014.

Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA.

Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA.

Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation.

Opna Immuno-Oncology SA is a Swiss biotechnology company that focuses on researching and developing biotechnology products. The private company is based in Saint-Sulpice, Switzerland.